ITCH and lung adenocarcinoma: These results indicate that down modulation of Itch expression decreases the chemoresistance of lung CSCs and suggest that the expression levels of Itch might be predictive to evaluate the chemotherapeutic response and, as a consequence, the survival of the lung adenocarcinoma affected patients.